research use only

Rimiducid (AP1903) Dimerizer Agent

Cat.No.S9726

Rimiducid (AP1903) is a chemical protein dimerizer that binds tightly to the target FKBP fusion protein while binding minimally to the abundant natural FKBP. This compound elicits potent and dose-dependent apoptosis of cells in culture expressing dimerizer-dependent Fas constructs, with an EC50 of ≈0.1 nM.
Jump to

Quality Control

Batch: S972601 DMSO]100 mg/mL]false]Ethanol]100 mg/mL]false]Water]Insoluble]false Purity: 99.89%
99.89

Solubility

In vitro
Batch:

DMSO : 100 mg/mL (70.84 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO.)

Ethanol : 100 mg/mL

Water : Insoluble

Molarity Calculator

Mass Concentration Volume Molecular Weight
Dilution Calculator Molecular Weight Calculator

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg
g
μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO
%
% Tween 80
% ddH2O
% DMSO
+
%

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Chemical Information, Storage & Stability

Molecular Weight 1411.63 Formula

C78H98N4O20

Storage (From the date of receipt) 3 years -20°C powder
CAS No. 195514-63-7 -- Storage of Stock Solutions

Synonyms N/A SMILES CCC(C(=O)N1CCCCC1C(=O)OC(CCC2=CC(=C(OC)C=C2)OC)C3=CC(=CC=C3)OCC(=O)NCCNC(=O)COC4=CC=CC(=C4)C(CCC5=CC(=C(OC)C=C5)OC)OC(=O)C6CCCCN6C(=O)C(CC)C7=CC(=C(OC)C(=C7)OC)OC)C8=CC(=C(OC)C(=C8)OC)OC

Read more about storage stability stock solution CAS number SMILES

Mechanism of Action

Targets/IC50/Ki
FKBP fusion protein
In vitro

Rimiducid (AP1903) induces effective and dose-dependent apoptosis in the culture expressing dimer-dependent Fas constructors, indicating that it causes the activation of Fas signaling without interference from endogenous FKBP.

In vivo

Eliciting a dose-dependent decrease in serum hGH levels with a half-maximal effective dose of 0.4±0.1 mg/kg, Rimiducid (AP1903) is functional in activating Fas signaling in vivo.

References

Clinical Trial Information

(data from https://clinicaltrials.gov, updated on 2026-05-15)

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT06066424 RECRUITING
Solid Tumors
M.D. Anderson Cancer Center
2023-10-24 PHASE1
NCT07553390 NOT_YET_RECRUITING
Breast Cancer
M.D. Anderson Cancer Center
2026-10-01 PHASE1
NCT06984341 WITHDRAWN
Systemic Lupus Erythematosus
Genentech, Inc.
2026-06-30 PHASE1
NCT03741127 ACTIVE_NOT_RECRUITING
Multiple Myeloma
Poseida Therapeutics, Inc.
2018-10-29 PHASE1
NCT07164469 NOT_YET_RECRUITING
Large B-cell Lymphoma; Hodgkin Lymphoma
M.D. Anderson Cancer Center
2026-12-28 PHASE2
NCT01494103 ACTIVE_NOT_RECRUITING
Acute Lymphoblastic Leukemia; Myelodysplastic Syndrome; Acute Myeloid Leukemia; Chronic Myelogenous Leukemia; Non Hodgkin Lymphoma; Hemophagocytic Lymphohistiocytosis; Familial Hemophagocytic Lymphohistiocytosis; Hemophagocytic Syndrome; Epstein Barr Virus Infection; X-linked Lymphoproliferative Disease
Baylor College of Medicine
2011-11 PHASE1

Read more about Clinical Trials

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.